Respiratory Viral Infections: Current and future therapeutics
27 October 2022 5:30pm–7:45pm
Experts in the field of viral respiratory infections will discuss current and future therapeutics. The topics include respiratory syncytial virus (RSV) epidemiology and treatment, cytomegalovirus (CMV) therapies and respiratory pathogen vaccine development.
Thank you for joining us!
Program
5.30 pm AEST (Brisbane) Dinner and Registrations
6.00 pm AEST (Brisbane) Welcome and Introductions
Chair-person: Dr Suzanne Parker, Deputy Director, CRE RESPOND, The University of Queensland Centre for Clinical Research
Moderator: Dr Andrew Burke, Thoracic Physician, The Prince Charles Hospital, Brisbane
6.05 - 6.25 pm AEST RSV - Epidemiology and Future Treatment Strategies
Prof Chris Blyth, University of Western Australia
6.30 - 6.50 pm AEST Current and Future Therapies for CMV Disease
Dr Michelle Yong, ID Physician PeterMac Institute, Melbourne
6.55 - 7.15 pm AEST Successes and Pitfalls in Respiratory Pathogen Vaccine Development
Prof Michael Nissen, Paediatric ID Physician and Clinical Microbiologist and Director of Research, The Prince Charles Hospital
7.20pm AEST Questions & Answers
We regret that parts of the Q&A session recording are difficult to hear.
Other upcoming sessions
Respiratory Infections: Tuberculosis
17 Oct 2024